21 CFR § 862.3840 Clinical Chemistry and Clinical Toxicology Devices

§ 862.3840 Sirolimus test system.

Current through Sep 8, 2026 · Read all of Part 862

⚠ 2 pending changes to Part 862

(a) Identification. A sirolimus test system is a device intended to quantitatively determine sirolimus concentrations in whole blood. Measurements are used as an aid in management of transplant patients receiving therapy with sirolimus.

(b) Classification. Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document: Sirolimus Test Systems.” See § 862.1(d) for the availability of this guidance document.

[69 FR 58259, Sept. 30, 2004]

← § 862.3830 Salicylate test system.§ 862.3850 Sulfonamide test system. →